PureTech Health (PRTC) Common Equity (2019 - 2025)
PureTech Health (PRTC) reported Common Equity of $305.7 million for Q4 2025, down 25.07% year-over-year from $407.9 million in Q4 2024, and down 18.7% on a QoQ basis from $376.0 million in Q2 2025.
PureTech Health (PRTC) has 6 years of Common Equity data on file, last reported at $305.7 million in Q4 2025.
- Quarterly Common Equity fell 25.07% year-over-year to $305.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $305.7 million (down 25.07% YoY) and the FY2025 annual result came in at $305.7 million, down 25.07% from the prior year.
- Common Equity retreated to $305.7 million in Q4 2025 per PRTC's latest filing, from $376.0 million in the prior quarter.
- Across five years, Common Equity topped out at $584.1 million in Q4 2021 and bottomed at $305.7 million in Q4 2025.
- The 4-year median for Common Equity is $407.9 million (2024), against an average of $444.3 million.
- The widest annual swing landed in 2022, when Common Equity decreased 6.26%; it then retreated 25.07% in 2025.
- Tracing PRTC's Common Equity over 4 years: stood at $584.1 million in 2021, then fell by 6.26% to $547.6 million in 2022, then dropped by 25.5% to $407.9 million in 2024, then dropped by 25.07% to $305.7 million in 2025.
- Per Business Quant, the three latest PRTC Common Equity figures stand at $305.7 million (Q4 2025), $376.0 million (Q2 2025), and $407.9 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -1.42 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 35.63 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 31.42 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 13.21 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.08 Bn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | 305.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 305.68 Mn |
| Jun 30, 2025 | 375.98 Mn |
| Dec 31, 2024 | 407.93 Mn |
| Dec 31, 2022 | 547.59 Mn |
| Dec 31, 2021 | 584.15 Mn |
| Dec 31, 2020 | 653.54 Mn |
| Dec 31, 2019 | 668.04 Mn |